A novel prognostic signature contributes to precision treatment in colon adenocarcinoma with KRAS mutation.

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)(2023)

引用 0|浏览8
暂无评分
摘要
We established a precise 36-gene prognostic signature with great performance in prognosis prediction of KRAS-mutant COAD providing a new strategy for personalized prognosis management and precision treatment for KRAS-mutant COAD.
更多
查看译文
关键词
colon adenocarcinoma,novel prognostic signature,precision treatment
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要